MetaVia Inc. SEC filings MTVA
MetaVia Inc. has 633 filings in SEC EDGAR's recent list, going back to Apr 8, 2015. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 28, 2026 | Oct 28, 2026 |
| 4 | Insider transaction | Oct 13, 2026 | Oct 12, 2026 |
| 3 | Initial insider ownership | Oct 13, 2026 | Oct 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 13, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 9, 2026 | Sep 9, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 9, 2026 | Jul 9, 2026 |
| 8-K |
Current report
Other events
|
Jul 2, 2026 | Jul 2, 2026 |
| 424B5 | Prospectus supplement | Jul 2, 2026 | — |
| 4 | Insider transaction | Jun 8, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 8, 2026 |
| S-8 | Employee stock plan registration | Jun 8, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 8, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 8, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 27, 2026 | May 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 18, 2026 | May 18, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 11, 2026 | May 11, 2026 |
| ARS | Annual report to shareholders | Apr 27, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 8, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 10, 2026 | Apr 10, 2026 |
| 424B3 | Prospectus | Apr 7, 2026 | — |
| EFFECT | Filing | Apr 6, 2026 | — |
| S-8 | Employee stock plan registration | Apr 3, 2026 | — |
| POS AM | Filing | Apr 3, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 26, 2026 | Mar 26, 2026 |
| 10-K | Annual report | Mar 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 18, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | Jan 27, 2026 | Jan 23, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 27, 2026 | Jan 23, 2026 |
| 4 | Insider transaction | Jan 27, 2026 | Jan 23, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 16, 2026 | Jan 15, 2026 |
| 424B4 | Prospectus | Jan 16, 2026 | — |
| EFFECT | Filing | Jan 15, 2026 | — |
| S-1MEF | Form s-1mef | Jan 15, 2026 | — |
| CORRESP | Letter to the SEC | Jan 14, 2026 | — |
| CORRESP | Letter to the SEC | Jan 14, 2026 | — |
| S-1/A | Amended registration statement | Jan 12, 2026 | — |
| CORRESP | Letter to the SEC | Jan 7, 2026 | — |
| CORRESP | Letter to the SEC | Jan 7, 2026 | — |
| FWP | Free writing prospectus | Jan 6, 2026 | — |
| CORRESP | Letter to the SEC | Jan 5, 2026 | — |
| CORRESP | Letter to the SEC | Jan 5, 2026 | — |
| 8-K |
Current report
Results of operations
|
Jan 5, 2026 | Jan 5, 2026 |
| S-1 | Registration statement | Jan 5, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 5, 2026 | Jan 5, 2026 |
| 8-K |
Current report
Other events
|
Dec 19, 2025 | Dec 19, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Dec 2, 2025 | Dec 2, 2025 |
| 8-K |
Current report
Listing notice
|
Nov 26, 2025 | Nov 26, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 7, 2025 | Nov 7, 2025 |
| 424B5 | Prospectus supplement | Nov 6, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 6, 2025 | Nov 6, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| DRS | Filing | Oct 17, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 4 | Insider transaction | Aug 13, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Other events
|
Aug 7, 2025 | Aug 7, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 4, 2025 | Aug 4, 2025 |
| EFFECT | Filing | Jul 10, 2025 | — |
| 424B3 | Prospectus | Jul 10, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 9, 2025 | Jul 9, 2025 |
| CORRESP | Letter to the SEC | Jul 8, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2025 | — |
| S-3 | Shelf registration | Jul 2, 2025 | — |
| 4 | Insider transaction | Jul 1, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 30, 2025 | Jun 30, 2025 |
| ARS | Annual report to shareholders | Jun 10, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Jun 10, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Listing notice
|
May 30, 2025 | May 29, 2025 |
| PRE 14A | Preliminary proxy statement | May 27, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Other events
|
May 21, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 8, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 20, 2025 | — |
| D | Filing | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
May 14, 2025 | May 8, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 7, 2025 | May 7, 2025 |
| UPLOAD | Letter from the SEC | May 6, 2025 | — |
| CORRESP | Letter to the SEC | May 2, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 22, 2025 | Apr 22, 2025 |
| 8-K |
Current report
Other events
|
Apr 15, 2025 | Apr 15, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 15, 2025 | Apr 15, 2025 |
| 424B3 | Prospectus | Apr 4, 2025 | — |
| EFFECT | Filing | Apr 3, 2025 | — |
| S-8 | Employee stock plan registration | Mar 27, 2025 | — |
| POS AM | Filing | Mar 27, 2025 | — |
| 10-K | Annual report | Mar 20, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2025 | Mar 20, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 18, 2024 | Dec 18, 2024 |
| 4 | Insider transaction | Dec 2, 2024 | Nov 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 29, 2024 | Nov 29, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Nov 18, 2024 | Nov 15, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 4, 2024 | Nov 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 7, 2024 | Oct 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 30, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Sep 20, 2024 | Sep 18, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Sep 20, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Sep 19, 2024 | Sep 18, 2024 |
| DEF 14A | Proxy statement | Aug 21, 2024 | Sep 18, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 13, 2024 | Aug 11, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 13, 2024 | Aug 13, 2024 |
| PRE 14A | Preliminary proxy statement | Aug 7, 2024 | Sep 18, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 30, 2024 | Jul 30, 2024 |
| EFFECT | Filing | Jul 24, 2024 | — |
| 424B3 | Prospectus | Jul 24, 2024 | — |
| CORRESP | Letter to the SEC | Jul 22, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 22, 2024 | — |
| S-1 | Registration statement | Jul 18, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 16, 2024 | Jul 16, 2024 |
| 4/A | Filing | Jul 10, 2024 | Jun 23, 2024 |
| D | Filing | Jul 1, 2024 | — |
| 8-K |
Current report
Other events
|
Jun 26, 2024 | Jun 26, 2024 |
| 4 | Insider transaction | Jun 25, 2024 | Jun 23, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Jun 25, 2024 | — |
| 424B5 | Prospectus supplement | Jun 25, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 25, 2024 | Jun 23, 2024 |
| 8-K |
Current report
Other events
|
Jun 24, 2024 | Jun 24, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 7, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Other events
|
May 22, 2024 | May 22, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 30, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 30, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Other events
|
Apr 30, 2024 | Apr 30, 2024 |
| EFFECT | Filing | Apr 23, 2024 | — |
| CORRESP | Letter to the SEC | Apr 19, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 17, 2024 | — |
| 8-K |
Current report
Other events
|
Apr 17, 2024 | Apr 17, 2024 |
| 8-K |
Current report
Other events
|
Apr 16, 2024 | Apr 16, 2024 |
| S-3 | Shelf registration | Apr 12, 2024 | — |
| 8-K |
Current report
Other events
|
Apr 1, 2024 | Apr 1, 2024 |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Other events
|
Mar 13, 2024 | Mar 13, 2024 |
| 4 | Insider transaction | Mar 4, 2024 | Mar 1, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 4, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Other events
|
Feb 29, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Other events
|
Feb 14, 2024 | Feb 14, 2024 |
| 8-K |
Current report
Other events
|
Feb 1, 2024 | Feb 1, 2024 |
| 8-K |
Current report
Other events
|
Jan 18, 2024 | Jan 18, 2024 |
| 8-K |
Current report
Other events
|
Jan 9, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Other events
|
Dec 28, 2023 | Dec 28, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Dec 19, 2023 | Dec 19, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 7, 2023 | Dec 7, 2023 |
| 4 | Insider transaction | Dec 4, 2023 | Dec 1, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Nov 6, 2023 | Nov 1, 2023 |
| 3 | Initial insider ownership | Nov 2, 2023 | Nov 1, 2023 |
| 3 | Initial insider ownership | Oct 30, 2023 | Oct 27, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 30, 2023 | Oct 25, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 22, 2023 | Sep 22, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 19, 2023 | Sep 18, 2023 |
| 8-K |
Current report
Other events
|
Sep 15, 2023 | Sep 15, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Aug 24, 2023 | Aug 23, 2023 |
| 4 | Insider transaction | Aug 14, 2023 | Aug 11, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Aug 14, 2023 | Aug 10, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Listing notice, Other events
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Other events
|
Aug 3, 2023 | Aug 3, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MTVA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1638287
- Former names
- NeuroBo Pharmaceuticals, Inc. (until Nov 18, 2024); Gemphire Therapeutics Inc. (until Dec 31, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.